Stockreport

CervoMed to Participate in Upcoming Investor Conferences

CervoMed Inc.  (CRVO) 
PDF BOSTON, March 05, 2026 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders, [Read more]